Cerci, K., and P. Patir. “Ruxolitinib As a Therapy Choice for Refractory Pruritus in a Patient With Essential Thrombocythemia With CALR Mutation”. Global Journal of Medical and Clinical Case Reports, vol. 10, no. 1, Jan. 2023, pp. 001-2, doi:10.17352/2455-5282.000167.